Filing Flows › Core Laboratories (CLB) › Free cash flow
Core Laboratories (CLB) free cash flow by quarter
Core Laboratories' free cash flow was $1.7M in Q3 2026 (third quarter 2026), -45% from Q2 2026. Over the last 7 quarters it ranged from $517K (Q1 2026) to $10.4M (Q2 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.7M | -45% | -73% |
| Q2 2026 | $3.1M | +504% | -70% |
| Q1 2026 | $517K | -90% | -87% |
| Q4 2025 | $5.0M | -23% | — |
| Q3 2025 | $6.5M | -38% | — |
| Q2 2025 | $10.4M | +170% | — |
| Q1 2025 | $3.9M | — | — |
Q3 2026 at a glance
Core Laboratories, Q3 2026: revenue $132M (-2% year over year), operating margin 9.1%, net earnings $5.4M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Core Laboratories' free cash flow?
Core Laboratories' free cash flow was $1.7M in Q3 2026 (third quarter 2026), -45% from Q2 2026.
How has Core Laboratories' free cash flow changed?
Over the last 7 quarters it ranged from $517K (Q1 2026) to $10.4M (Q2 2025).